Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

8,576 total articles

Buy the Dip in Alphabet: Weather the Jump-Slump, Hold for Rebound

Buy the Dip in Alphabet: Weather the Jump-Slump, Hold for Rebound

Alphabet (GOOGL) has pulled back after a brief 'jump' in sentiment; this trade idea recommends entering at $160.00 with a stop at $145.00 and a target of $205.00 on a mid-term, 45 trading day horizon. The thesis: core ad revenue and accelerating AI/cloud monetization provide a durable earnings floor while near-term multiples can expand on positive …

RideNow Group: Buy the Pullback — A Practical Mid-Term Trade

RideNow Group: Buy the Pullback — A Practical Mid-Term Trade

RideNow Group (RDNW) looks appealing after a pullback from its May highs. The company trades at roughly $254.7M market cap with free cash flow of $14M and an EV/sales of 0.63. Technicals show oversold momentum while short interest and active short-volume create a setup for a mid-term mean-reversion into the $8s. This trade lays out a clear entry at…

Hubbell: Buy the Grid Upgrade, Ride the M&A-Driven Re-rating

Hubbell: Buy the Grid Upgrade, Ride the M&A-Driven Re-rating

Hubbell (HUBB) is a high-quality electrical-products compounder trading at a premium multiple but backed by strong cash flow, robust ROE, and acquisitive growth that plugs directly into the electrification and smart-building upcycle. Enter around $518.00 with a $565.50 target and $485.00 stop; the setup balances catalyst-driven upside with defined …

EPAM: Cheap Access to a Hard-to-Replicate AI Engineering Moat

EPAM: Cheap Access to a Hard-to-Replicate AI Engineering Moat

EPAM trades near $77 after a brutal re-rating tied to a large customer ramp-down disclosure and class-action noise. Fundamentals still show healthy cash generation ($543.6M FCF), low leverage (debt/equity 0.05) and an attractive valuation (EV/EBITDA ~4.7). This trade idea argues the market has overshot on headline risk and that a measured long with…

Scorpio Tankers: Buy for Yield + Buybacks as TCEs Stay Elevated

Scorpio Tankers: Buy for Yield + Buybacks as TCEs Stay Elevated

Scorpio Tankers (STNG) looks buyable here. Elevated Time Charter Equivalent (TCE) rates, a string of asset sales and long-term charters, and recent convertible-note issuances tied to targeted share repurchases give the company both cash and a visible path to accelerate capital returns. The stock trades at a modest P/E of 7.5 and a PB of ~1.22 with …

Label Path and Clinical Momentum: A Tactical Long on MoonLake (MLTX)

Label Path and Clinical Momentum: A Tactical Long on MoonLake (MLTX)

MoonLake Immunotherapeutics has materially de‑risked its lead program after FDA confirmations and positive Week 40 Phase 3 data. With cash runway into late 2027 and an upcoming BLA submission in H2 2026, the stock looks positioned for a re-rating if 52‑week data and regulatory engagement continue to favor approval. We outline a long trade with entr…

Novo Nordisk: Buying the Panic - A Contrarian Trade After the Big Reset

Novo Nordisk: Buying the Panic - A Contrarian Trade After the Big Reset

Novo Nordisk ($NVO) has been hammered to the mid-$40s after a year of pricing and competitive concerns. The selloff has pushed the stock to a single-digit P/E near 10x and a market cap of about $204 billion. Management is buying shares back and core obesity/diabetes demand remains sizable. This trade idea proposes a buy at $46.50, with a $42.00 sto…

Whitbread: Estate Disposals Can Fund a 15% Annualized Return

Whitbread: Estate Disposals Can Fund a 15% Annualized Return

Whitbread will likely unlock material cash by selectively disposing of parts of its estate. If management executes disciplined estate recycling, proceeds can fund buybacks, debt paydown and reinvestment, supporting a mid-single-digit multiple re-rate. We initiate a tactical long aiming for ~15% annualized return, with defined entry, stop and target…

Moderna’s Rebound: A Swing Trade to Ride the Approval Wave

Moderna’s Rebound: A Swing Trade to Ride the Approval Wave

Moderna is staging a comeback after a strong run this year. With an FDA decision on its mRNA influenza candidate due 08/05/2026, solid clinical progress across multiple programs, $7.5B in cash and improving technicals, the stock looks set for another leg higher. This trade idea lays out an actionable swing entry, stop and target with rationale and …

Micron to $1,600: Buy the Post-Earnings AI Repricing

Micron to $1,600: Buy the Post-Earnings AI Repricing

Micron's core memory business sits squarely in the bottleneck layer of the AI infrastructure buildout. With a $1.36T market cap, double-digit ROE, and a multi-year supply agreement with Anthropic, the stock can re-rate to $1,600 after a strong report on 06/24/2026. This trade plan gives a concrete entry, stop and target, with clear horizon and risk…

Deep-Value Swing Trade: Meren Energy Looks Like an Outright Steal

Deep-Value Swing Trade: Meren Energy Looks Like an Outright Steal

Meren Energy (MREN) is trading at deeply depressed levels after a year of sector-wide weakness. The company appears to offer an asymmetric risk-reward: a defined entry at $3.50, a protective stop at $2.80 and a first target at $6.00 as near-term catalysts and structural operational gains drive re-rating over the next 45 trading days.